Omega Biologicals
Private Company
Funding information not available
Overview
Omega Biologicals is a long-established, private US company that operates as a foundational supplier to the global IVD industry, providing essential raw materials like antibodies, antigens, and its proprietary HeteroBlock® reagent. The company's value proposition lies in its ability to develop and manufacture high-purity, application-specific biological components upon which diagnostic kit manufacturers rely for FDA-approved products. With nearly four decades of operation, it has built a reputation for quality and customer service, catering to leading diagnostic firms. Its business model is focused on the B2B supply chain within the diagnostics sector, rather than direct therapeutic or diagnostic kit development.
Technology Platform
Proprietary technology for manufacturing high-specificity antibodies, antigens, and the HeteroBlock® blocking reagent for diagnostic immunoassays. Capabilities include custom protein development and purification to client specifications.
Opportunities
Risk Factors
Competitive Landscape
Omega Biologicals competes in the niche market of diagnostic raw materials against larger, diversified life science reagent suppliers (e.g., Thermo Fisher, Abcam, Merck) and smaller specialty antibody producers. Its competitive advantages are its long-standing industry relationships, focus on IVD-specific quality, proprietary HeteroBlock® technology, and US-based manufacturing.